Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 346 to 360 of 9024 results

  1. Acalabrutinib with bendamustine and rituximab for untreated mantle cell lymphoma [ID6155]

    In development Reference number: GID-TA11091 Expected publication date:  04 June 2026

  2. Nusinersen and risdiplam for treating spinal muscular atrophy (review of TA588 and TA755) [ID6195]

    In development Reference number: GID-TA11386 Expected publication date:  04 June 2026

  3. Advanced breast cancer: diagnosis and management (Partial update)

    In development Reference number: GID-NG10430 Expected publication date:  05 June 2026

  4. Stable angina

    All NICE products on stable angina. Includes any guidance, advice and quality standards.

  5. Hypertension

    All NICE products on hypertension. Includes any guidance and quality standards.

  6. Vasculitis

    All NICE products on vasculitis. Includes any guidance.

  7. Eye conditions

    All NICE products on eye conditions. Includes any guidance, advice and quality standards.

  8. Faecal incontinence

    All NICE products on faecal incontinence. Includes any guidance, advice and quality standards.

  9. Diarrhoea and vomiting

    All NICE products on diarrhoea and vomiting. Includes any guidance and advice.

  10. ME/CFS

    All NICE products on ME/CFS. Includes any guidance.

  11. Addiction

    All NICE products on addiction. Includes any guidance and advice.

  12. Anxiety

    All NICE products on anxiety. Includes any guidance and quality standards.

  13. Attention deficit disorder

    All NICE products on attention deficit disorder. Includes any guidance and quality standards.

  14. Autism

    All NICE products on autism. Includes any guidance and quality standards.

  15. Depression

    All NICE products on depression. Includes any guidance and quality standards.